Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · IEX Real-Time Price · USD
1.150
0.00 (0.00%)
At close: Apr 24, 2024, 3:59 PM
1.140
-0.010 (-0.87%)
After-hours: Apr 24, 2024, 4:00 PM EDT

Co-Diagnostics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018201720162015
Cash & Equivalents
14.9222.9788.6142.980.890.953.5310.03
Short-Term Investments
43.6358.361.334.3400000
Cash & Cash Equivalents
58.5581.3489.9447.310.890.953.5310.03
Cash Growth
-28.02%-9.56%90.09%5197.30%-6.01%-73.12%253.89%2854.41%-
Receivables
0.33.4520.8412.140.130.01000
Inventory
1.665.31280.20.020.0100
Other Current Assets
1.622.632.340.370.360.070.910.210.12
Total Current Assets
62.1492.73115.1267.811.581.054.451.210.15
Property, Plant & Equipment
62.911.930.950.20.160.170.090.11
Long-Term Investments
0.770.671.081.930.430.350.0400
Goodwill and Intangibles
26.426.7741.9000000
Other Long-Term Assets
0000.5500000.11
Total Long-Term Assets
33.1830.3544.913.420.630.50.210.090.22
Total Assets
95.32123.09160.0371.242.221.554.661.30.37
Accounts Payable
1.480.950.610.60.010.150.040.10.11
Deferred Revenue
0.3600.150.31000.1900
Current Debt
0.840.30001.9102.950.49
Other Current Liabilities
3.062.6211.843.160.320.290.390.790.39
Total Current Liabilities
5.753.8712.64.060.332.350.633.850.99
Long-Term Debt
2.150.05000000.450.52
Other Long-Term Liabilities
1.414.6412.960.480.150.260.1800
Total Long-Term Liabilities
3.564.6912.960.480.150.260.180.450.52
Total Liabilities
9.318.5725.564.540.482.610.814.291.52
Total Debt
2.990.350001.9103.391.01
Debt Growth
759.56%------235.54%-
Retained Earnings
4.639.9354.1717.51-24.97-18.69-12.42-5.46-3.53
Comprehensive Income
0.150.290000000
Shareholders' Equity
86.01114.52134.4866.71.74-1.063.85-2.99-1.15
Net Cash / Debt
55.5680.9989.9447.310.89-0.963.53-2.4-0.98
Net Cash / Debt Growth
-31.40%-9.95%90.09%5197.30%-----
Net Cash Per Share
1.892.573.011.690.05-0.080.32-0.24-0.10
Working Capital
56.3988.86102.5263.751.26-1.33.82-2.64-0.84
Book Value Per Share
2.933.644.662.500.10-0.090.35-0.30-0.12
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).